We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Trends in FDA Good Manufacturing Practice Warning Letters

July 2009

RAJ (Regulatory Affairs Journal) Pharma
Recent U.S. Food and Drug Administration (FDA) warning letters provide clues to pharmaceutical companies about how they can enhance their quality systems, improve their manufacturing processes and more effectively manage future FDA establishment inspections, say Rob Church and Steve Mahoney.


Loading data